Biomarker Strategies to Identify Patients With Resistance to Current Immunotherapies

Time: 11:40 am
day: Day 1 red


• Review the current understanding on what determines resistance to immunotherapies
• Summary of available biomarker strategies
• Show cases/examples on how to detect resistance mechanisms in patients (such as Tregs, MDSCs, CAFs)
• Impact on current oncology clinical trial endpoints